UNICHEM LABORATORIES
|
|
BOM : 506690     NSE : UNICHEMLAB     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Oct 10,2024 |
Price(EOD): ₹ 669.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 4,715.04 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
UNICHEM LABORATORIES | 5.5% | 16.9% | 53% |
SUN PHARMACEUTICAL INDUSTRIES | -1.2% | 2.8% | 71.4% |
CIPLA | -0.3% | -0.8% | 44.6% |
DR REDDYS LABORATORIES | -0.8% | -1% | 23% |
ZYDUS LIFESCIENCES | -0% | -5% | 76.5% |
DIVIS LABORATORIES | 9.6% | 9.4% | 60.9% |
FUNDAMENTAL ANALYSIS OF UNICHEM LABORATORIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF UNICHEM LABORATORIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-77.87
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -60.55 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 2
P/B Calculated based on Book Value of Rs 2,359.35 Cr
[Latest Year - Mar2024 - Consolidated Results ] 2.73
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,728.14 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 62% 56% |
SHARE PRICE MOMENTUM OF UNICHEM LABORATORIES
UNICHEM LABORATORIES vs SENSEX
DEBT OF UNICHEM LABORATORIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.03 0.04 0.05 0.04 |
0.09 0.12 0.13 0.11 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF UNICHEM LABORATORIES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF UNICHEM LABORATORIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.41% 71.58% 111.92% 107.16% |
5.49% 55.24% 608.46% 1485.48% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
UNICHEM LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 0.7% | 1.6% | 57.8% |
S&P BSE SMALL CAP | -0.1% | 1.3% | 49.7% |
S&P BSE MIDSMALLCAP | -0.2% | 0.6% | 50.5% |
S&P BSE ALLCAP | -0.6% | 0.3% | 37.5% |
You may also like the below Video Courses
FAQ about UNICHEM LABORATORIES
Is UNICHEM LABORATORIES good for long term investment?
As on Oct 10,2024, the Fundamentals of UNICHEM LABORATORIES look Poor and hence it may not be good for long term investment ! See Financial Performance of UNICHEM LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is UNICHEM LABORATORIES UnderValued or OverValued?
As on Oct 10,2024, UNICHEM LABORATORIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of UNICHEM LABORATORIES ?
As on Oct 10,2024, the Intrinsic Value of UNICHEM LABORATORIES is Rs. 421.11 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -125.05
Fair Value [Median EV / Sales Model] : Rs. 413.08
Fair Value [Median Price / Sales Model] : Rs. 429.14
Estimated Median Fair Value of UNICHEM LABORATORIES : Rs. 421.11
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.